In conclusion, based on the biomarkers of tumor progression resulting from the studies in 3D cultures of the MPA breast cancer model, it will be possible in the future to design and test multi-targeted treatments involving a combination of selective inhibitors of endocrine response, protein kinases and extracellular matrix signals. Here, WEE1 is linked to breast carcinoma.